Type of publications
Regions
Countries
Diseases
Publication date

JCVI statement on COVID-19 vaccination of children and young people aged 12 to 17 years: 15 July 2021

adolescents children Recommendation United Kingdom COVID-19
Download:
Published: 2021 Author: JCVI

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021

mRNA vaccines Recommendation United States of America COVID-19
Download:
Published: 2021 Author: ACIP

JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022 - 30 June 2021

booster dose Recommendation United Kingdom COVID-19
Download:
Published: 2021 Author: JCVI

STIKO resolution on the 8th update of the COVID-19 vaccination recommendation and the associated scientific justification - 8 July 2021

AstraZeneca COVID-19 vaccine mRNA vaccines Recommendation Germany COVID-19
Download:
Published: 2021 Author: STIKO

HAS Sars-Cov-2 vaccination strategy - Role of socio-economic and professional factors in the risk of infection and severe forms of Covid-19 and updating of recommendations - 1 July 2021

Priority Groups Recommendation France COVID-19
Download:
Published: 2021 Author: Haute Autorité de Santé

Statement on the Clinical use of Zoster vaccine in older adults in Australia - 8 July 2021

Recommendation Australia Herpes zoster
Download:
Published: 2021 Author: ATAGI

Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium - 9 July 2021

children adolescents Recommendation Belgium COVID-19
Download:
Published: 2021 Author: Conseil Supérieur de la Santé (CSS)

WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply - 16 July 2021

Priority Groups Position paper COVID-19
Download:
Published: 2021 Author: SAGE

A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19

Rating : Critically low
Vaccine/vaccination All age groups COVID-19
Published: 2021

A Systematic Review and Meta-analysis of Clinical Characteristics and Outcomes in Lung Cancer Patients with COVID-19

Rating : Critically low
Risk factor All age groups COVID-19
Published: 2021